A new preliminary study published in Nature suggests that COVID-19 vaccines might actually boost the immune system to make ...

The first iteration of HER2-targeted drugs showed limited activity in bladder cancer, but the rise of antibody-drug ...

Patients with cancer who received mRNA-based COVID vaccines within 100 days of starting immune checkpoint therapy were twice ...

Groundbreaking research reveals mRNA COVID-19 vaccines may significantly boost cancer immunotherapy success. Patients ...

Farber-co-led phase 3 trial shows that periodic ctDNA screening after surgery can help guide a decision to begin adjuvant ...

US FDA grants priority review for Keytruda & Keytruda Qlex, each in combination with Padcev, for certain patients with muscle-invasive bladder cancer: Rahway, New Jersey Friday, O ...

Discusses 2-Year Phase II Data and AI Immunology Platform in High-Risk Melanoma October 22, 2025 10:30 AM EDTCompany ...

Objectives Patients with primary Sjögren’s disease (SjD) have an increased risk of B cell lymphoma. The aim of this study was ...

Radiopharm Theranostics Limited (($AU:RAD)) announced an update on their ongoing clinical study. Study Overview: Radiopharm Theranostics Limited ...

Bristol-Myers Squibb Company has had a recent 30% stock decline amid concerns over patent expirations. Click here to read why BMY stock is a Hold.